Peter Radovich insider trades

Open-market stock purchases and sales by Peter Radovich, PRESIDENT AND COO at Mirum Pharmaceuticals, Inc, from SEC Form 4 filings since Aug 17, 2015.

Recent trades

DateStockTradeValue
Jun 5, 2026MIRM Mirum Pharmaceuticals, IncBought (not open market)—
Mar 16, 2026MIRM Mirum Pharmaceuticals, IncSold$1.5M
Mar 15, 2026MIRM Mirum Pharmaceuticals, IncBought (not open market)—
Mar 15, 2026MIRM Mirum Pharmaceuticals, IncBought (not open market)—
Mar 6, 2026MIRM Mirum Pharmaceuticals, IncBought (not open market)—
Feb 2, 2026MIRM Mirum Pharmaceuticals, IncSold$272K
Jan 28, 2026MIRM Mirum Pharmaceuticals, IncBought (not open market)—
Jan 28, 2026MIRM Mirum Pharmaceuticals, IncBought (not open market)—
Jan 28, 2026MIRM Mirum Pharmaceuticals, IncBought (not open market)—
Jan 26, 2026MIRM Mirum Pharmaceuticals, IncSold$302K
Jan 23, 2026MIRM Mirum Pharmaceuticals, IncBought (not open market)—
Jan 22, 2026MIRM Mirum Pharmaceuticals, IncSold$222K
Jan 21, 2026MIRM Mirum Pharmaceuticals, IncBought (not open market)—

Companies traded

  • MIRM Mirum Pharmaceuticals, Inc: 16 sales, last Jun 5, 2026
  • RAIN Rain Oncology Inc: other filings, last Jan 26, 2024
  • GBT Global Blood Therapeutics, Inc: 1 buy, 5 sales, last Feb 14, 2018

Get free alerts when Peter Radovich files a new trade →